Status:
TERMINATED
Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Pear Therapeutics, Inc.
Conditions:
Opioid-use Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This randomized controlled pilot study will evaluate feasibility, acceptability, and potential efficacy of an app, reSET-O, for patients being started on buprenorphine in acute care settings.
Detailed Description
This randomized controlled pilot study will enroll 60 participants, who will be randomly assigned to a treatment as usual (TAU) group or a reSET-O+TAU group after being started on buprenorphine in acu...
Eligibility Criteria
Inclusion
- 18-65 years old
- Opioid use disorder
- Eligible for buprenorphine treatment
- Has reSET-O compatible mobile device
Exclusion
- Pregnancy
- Significant psychiatric comorbidity
Key Trial Info
Start Date :
March 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04817267
Start Date
March 11 2022
End Date
May 1 2024
Last Update
May 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Bayivew Emergency Department
Baltimore, Maryland, United States, 21224